Bullish Stock
Business, News, US Markets

Investors Cheer as AbbVie (NYSE: ABBV) Announces Multi-Billion Dollar Purchase of ImmunoGen

/

Biopharmaceutical giant AbbVie (NYSE: ABBV) has agreed to acquire ImmunoGen (NASDAQ: IMGN) in a blockbuster deal worth $10.1 billion, sending […]

Investors Cheer as AbbVie (NYSE: ABBV) Announces Multi-Billion Dollar Purchase of ImmunoGen Read More »